Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |